Ketorolac is more cost effective than morphine for limb injury

Doctors working in accident and emergency departments are finding it increasingly difficult to provide cost effective care for patients. In the management of patients with painful limb injuries the use of less expensive strong analgesia may seem appropriate. On p 1247 Rainer et al show, however, that when additional emergency department and hospital costs are taken into account, the more expensive ketorolac is no more expensive than morphine. If emergency department and pharmacy costs are considered separately from total hospital costs, then ketorolac is cheaper, gives equal pain relief, is associated with less severe and fewer adverse effects, shortens patients' stay in the emergency department, and is associated with greater patient satisfaction.


Add to CiteULike CiteULike   Add to Complore Complore   Add to Connotea Connotea   Add to Del.icio.us Del.icio.us   Add to Digg Digg   Add to Reddit Reddit   Add to Technorati Technorati    What's this?

Relevant Article

Cost effectiveness analysis of intravenous ketorolac and morphine for treating pain after limb injury: double blind randomised controlled trial
Timothy H Rainer, Philip Jacobs, Y C Ng, N K Cheung, Michael Tam, Peggo K W Lam, Robert Wong, and Robert A Cocks
BMJ 2000 321: 1247. [Abstract] [Full Text] [PDF]




Access all current jobs at BMJ Group
Whats new online at Student 

BMJ
Listen to the latest 

BMJ Interview